Bracing for Market Cold Snap, Molecular Mining Restructures, Reins in Discovery Plans | GenomeWeb

In a “proactive” reaction to increasingly feeble market conditions, Molecular Mining has taken steps to limit spending and refocus its resources, CEO Evan Steeg told BioInform last week. The company laid off an undisclosed number of employees in central R&D and administration, according to Steeg, as it implements a near-term strategy to concentrate on software sales and collaborative research agreements, while pulling back on its in-house discovery projects.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.